Gjestad et al. et al. reply to ‘Was 4β‐hydroxycholesterol ever going to be a useful marker of CYP3A4 activity?’ by Neuhoff and Tucker

Gjestad Caroline; Haslemo Tore; Andreassen Ole A.; Molden Espen

首页> 外文期刊>British Journal of Clinical Pharmacology >Gjestad et al. et al. reply to ‘Was 4β‐hydroxycholesterol ever going to be a useful marker of CYP3A4 activity?’ by Neuhoff and Tucker

【24h】

Gjestad et al. et al. reply to ‘Was 4β‐hydroxycholesterol ever going to be a useful marker of CYP3A4 activity?’ by Neuhoff and Tucker

机译：gjestad等。等等。回复“是4β-羟基胆固醇，永远是CYP3A4活动的有用标记？'通过Neuhoff和Tucker

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《British Journal of Clinical Pharmacology》 |2018年第7期|共2页
作者
Gjestad Caroline; Haslemo Tore; Andreassen Ole A.; Molden Espen;
展开▼
作者单位

Center for PsychopharmacologyDiakonhjemmet HospitalOslo Norway;

Center for PsychopharmacologyDiakonhjemmet HospitalOslo Norway;

NORMENT KG Jebsen Centre for Psychosis ResearchInstitute of Clinical Medicine University of;

Center for PsychopharmacologyDiakonhjemmet HospitalOslo Norway;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词
4β‐hydroxycholesterol; CYP3A4; quetiapine;

机译：4β-羟基胆固醇;CYP3A4;Quetiapine;

相似文献

外文文献

1. Gjestad et al. et al. reply to ‘Was 4β‐hydroxycholesterol ever going to be a useful marker of CYP3A4 activity?’ by Neuhoff and Tucker [J] . Gjestad Caroline, Haslemo Tore, Andreassen Ole A., British Journal of Clinical Pharmacology . 2018,第7期

机译：gjestad等。等等。回复“是4β-羟基胆固醇，永远是CYP3A4活动的有用标记？'通过Neuhoff和Tucker
2. Was 4β 4β ‐hydroxycholesterol ever going to be a useful marker of CYP3A4 CYP3A4 activity? [J] . Neuhoff Sibylle, Tucker Geoffrey T. British Journal of Clinical Pharmacology . 2018,第7期

机译：是4β4β-羟基胆固醇将是CYP3A4 CYP3A4活动的有用标志物吗？
3. Comments to the Letter to the Editor of S. Shahsavari et al. concerning “Predicting medical complications in spine surgery: evaluation of a novel online risk calculator” by M. F. Kasparek et al. (Eur Spine J: doi:10.1007/s00586-018-5707-9) and the reply to the Letter to the Editor of S. Shahsavari et al. concerning “Predicting medical complications in spine surgery: evaluation of a novel online risk calculator” by M. F. Kasparek et al. (Eur Spine J: doi:10.1007/s00586-018-5707-9) [J] . Kimberley L. Edwards European spine journal: official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society . 2018,第11期

机译：对Shahsavari等人编辑的信致函。关于“预测脊柱手术中的医学并发症：评估新的在线风险计算器”由M.F.Kasparek等。（EUR SPINE J：DOI：10.1007 / S00586-018-5707-9）和给Shahsavari等人编辑的信函的回复。关于“预测脊柱手术中的医学并发症：评估新的在线风险计算器”由M.F.Kasparek等。（EUR SPINE J：DOI：10.1007 / S00586-018-5707-9）
4. Gjestad et al. reply to ‘Was 4β‐hydroxycholesterol ever going to be a useful marker of CYP3A4 activity?’ by Neuhoff and Tucker [O] . Caroline Gjestad, Tore Haslemo, Ole A. Andreassen, 2018

机译：Gjestad等。 Neuhoff和Tucker对4β-羟基胆固醇是否会成为CYP3A4活性的有用标志物？的回答
5. Table 2: List of few marine microbial species reported to produce bioactive metabolites with antibiofilm and antifouling activities (Abu Sayem et al., 2011; Arai, Niikawa Kobayashi, 2013; Busetti et al., 2015; Dos Santos et al., 2010; Estrela Abraham, 2016; Fusetani, 2011; Hong Cho, 2013; Jiang et al., 2011; Salta et al., 2013; Satheesh, Ba-Akdah Al-Sofyani, 2016; Scopel et al., 2014; Shao et al., 2015; Shao et al., 2011; Yang et al., 2007). [O] . -1

机译：表2：少数海洋微生物物种列表与抗触发和防污活动的产品生物活性代谢物报告（Abu Sayem等，2011; Arai，Niikawa＆Kobayashi，2013; Busetti等，2015;两个Santos等，2010 ; Estrela＆Abraham，2016; Fuseani，2011; 2013年Hong＆Cho;江等人，2011;萨尔塔等，2013; Satheesh，Ba-Akdah＆Al-Sofyani，2016; Scopel等，2014; 2014;邵等人，2015;邵等，2011;杨等人，2007）。

Gjestad et al. et al. reply to ‘Was 4β‐hydroxycholesterol ever going to be a useful marker of CYP3A4 activity?’ by Neuhoff and Tucker

著录项

相似文献

相关主题

期刊订阅